Literature DB >> 9556601

Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts.

I Nakamura1, E Jimi, L T Duong, T Sasaki, N Takahashi, G A Rodan, T Suda.   

Abstract

Integrin-mediated interaction with the extracellular matrix plays a critical role in the function of osteoclasts, the bone-resorbing cells. This study examines the role of p130Cas (Crk-associated substrate (Cas)) in actin organization in osteoclasts. Multinucleated osteoclast-like cells (OCLs) were obtained in a co-culture of murine bone marrow cells and primary osteoblasts. After plating on culture dishes, OCLs formed a ringlike structure consisting of F-actin dots at cell periphery (actin ring). The percentage of OCLs with actin rings and its diameter increased with time and cell spreading. Tyrosine phosphorylation of a protein (p130) increased with actin ring formation. Treatment with cytochalasin D disrupted actin rings and reduced tyrosine phosphorylation of p130. Using specific antibodies, p130 was identified as Cas. By immunocytochemistry, Cas was localized to the peripheral regions of OCLs and its distribution overlapped that of F-actin. In OCLs derived from Src(-/-) mice, in which osteoclast activity is severely compromised, tyrosine phosphorylation of Cas was markedly reduced. Moreover, Cas was diffusely distributed in the cytoplasm and actin ring formation is not observed. These findings suggest that Src-dependent tyrosine phosphorylation of Cas is involved in the adhesion-induced actin organization associated with osteoclast activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9556601     DOI: 10.1074/jbc.273.18.11144

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Regulation of osteoclast formation and function.

Authors:  L T Duong; G A Rodan
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  Involvement of alpha(v)beta3 integrins in osteoclast function.

Authors:  Ichiro Nakamura; Le T Duong; Sevgi B Rodan; Gideon A Rodan
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

3.  Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity.

Authors:  Niroshani S Soysa; Neil Alles; Hitoyata Shimokawa; Eijiro Jimi; Kazuhiro Aoki; Keiichi Ohya
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

4.  The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.

Authors:  Virginie Vives; Mélanie Laurin; Gaelle Cres; Pauline Larrousse; Zakia Morichaud; Danièle Noel; Jean-François Côté; Anne Blangy
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

5.  Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival.

Authors:  L Xing; A M Venegas; A Chen; L Garrett-Beal; B F Boyce; H E Varmus; P L Schwartzberg
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

6.  c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation.

Authors:  Brooke K McMichael; Stephanie M Meyer; Beth S Lee
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

7.  PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.

Authors:  L T Duong; P T Lakkakorpi; I Nakamura; M Machwate; R M Nagy; G A Rodan
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

Review 9.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

10.  Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts.

Authors:  Angela Bruzzaniti; Lynn Neff; Amanda Sandoval; Liping Du; William C Horne; Roland Baron
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.